Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Comparative Study of HEMAX PFS® Versus EPREX/ ERYPO® in the Treatment of Anemia With Epoetin Alfa in Patients With Predialysis Chronic Kidney Disease

NCT04036253 is registered in ClinicalTrials.gov with Bio Sidus SA as lead sponsor.

NCT NCT04036253
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04036253 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Comparative Study of HEMAX PFS® Versus EPREX/ ERYPO® in the Treatment of Anemia With Epoetin Alfa in Patients With Predialysis Chronic Kidney Disease
Lead sponsor
Bio Sidus SA
Phase
Phase 3
Overall status
Completed
Start date
February 28, 2018
Completion date
August 31, 2021
Enrollment
43 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

anemia of chronic kidney disease